Biomax, Pierre Fabre Collaborate
News Jun 19, 2015
Using the BioXM Knowledge Management Environment, Biomax created the antibody knowledgebase, which offers sequence analysis and storage capabilities, infrastructure for sharing in-house data and algorithms, a collection of public data, and includes both public and third-party algorithms.
Following a successful pilot project, Pierre Fabre has licensed Biomax's BioXM Knowledge Management Environment and agreed to work with the company to further develop and expand the system.
Pioneering Method Enables Screening Millions of Human Antibodies for Rapid Therapeutic DiscoveryNews
A paper just published in Nature Biotechnology outlines a pioneering method of screening a person's diverse set of antibodies for rapid therapeutic discovery.READ MORE
Safety and Efficacy of MERS Treatment Confirmed in Phase I TrialNews
An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.READ MORE